Diagnosis at age 3–5 years showed an elevated point estimate for enrolling in therapeutic trials compared to no trial, relative to diagnosis at age < 1 year (OR = 2.70; 95% CI = 0.84, 8.74), but this difference did not reach statistical significance.
← all excerpts
Patterns of Clinical Trial Enrollment for Pediatric Patients With Hepatoblastoma and Wilms Tumor: A Report From the Children's Oncology Group.
1
—
—